Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2019-07-25 4:53 pm Purchase | 13G | XENETIC BIOSCIENCES INC PA XBIO | Altium Capital Management LP | 260,000 9.8% | 260,000 (New Position) | View |
| 2019-07-22 5:08 pm Purchase | 13G | DELCATH SYS INC PAR $0.01 DCTH | Altium Capital Management LP | 38,333,333 9.9% | 38,333,333 (New Position) | View |
| 2019-07-19 7:19 pm Purchase | 13G | SAVARA INC SVRA | Altium Capital Management LP | 2,368,000 6.27% | 2,368,000 (New Position) | View |
| 2019-07-01 6:01 pm Purchase | 13G | ALLENA PHARMACEUTICALS COM ALNA | Altium Capital Management LP | 2,340,136 9.98% | 2,340,136 (New Position) | View |
| 2019-06-24 09:30 am Purchase | 13G | SELLAS LIFE SCIENCES GROUP INC SLS | Altium Capital Management LP | 16,666,600 9.7% | 13,866,600 (+495.24%) | View |
| 2019-06-05 10:30 am Purchase | 13G | OPIANT PHARMACEUTICALS INC OPNT | Altium Capital Management LP | 252,873 6.3% | 252,873 (New Position) | View |
| 2019-05-30 5:10 pm Purchase | 13G | ONCOSEC MED INC ONCS | Altium Capital Management LP | 952,000 9.99% | 952,000 (New Position) | View |
| 2019-05-23 5:02 pm Purchase | 13G | AURIS MED HLDG LTD SHS PA EARS | Altium Capital Management LP | 897,435 9.9% | 897,435 (New Position) | View |
| 2019-05-17 2:00 pm Purchase | 13G | REGULUS THERAPEUTICS INC RGLS | Altium Capital Management LP | 1,327,801 9.99% | 1,327,801 (New Position) | View |